Digital health technologies in clinical trials for central nervous system drugs: an EU regulatory perspective

Nat Rev Drug Discov. 2021 Feb;20(2):83-84. doi: 10.1038/d41573-020-00168-z.
No abstract available

Publication types

  • Review

MeSH terms

  • Biomedical Technology / legislation & jurisprudence*
  • Central Nervous System Agents*
  • Clinical Trials as Topic / legislation & jurisprudence*
  • Drug and Narcotic Control / legislation & jurisprudence*
  • European Union*
  • Humans
  • Telemedicine / legislation & jurisprudence*

Substances

  • Central Nervous System Agents